Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
1990
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
1990
Untangling the ErbB signalling network
2001 Standout
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010 Standout
Immunohistochemical Study of c-erbB-2 Protein in Colorectal Cancer and the Correlation with Patient Survival
1998
Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies
1993
Overexpression of HER2/neu oncogene in human pancreatic carcinoma
1993
ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma
1996
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
c-erb B2 amplification and overexpression in human tumors
1991
Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu
1989
EGFR and cancer prognosis
2001 Standout
Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries
1992
Serial serum c-erbB-2 levels in patients with breast carcinoma
1996
Cytogenetics and DNA amplification in colorectal cancers
1990
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Embryo Implantation
2000 Standout
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
2000 Standout
Biochemical analysis of the ligand for the neu oncogenic receptor
1991
Recent Insights into the Functions of the Retinoblastoma Susceptibility Gene Product
1997 StandoutNobel
THE LOCALIZATION OF p34cdc2 IN THE CELLS OF NORMAL, HYPERPLASTIC, AND MALIGNANT EPITHELIAL AND LYMPHOID TISSUES OF THE ORAL CAVITY
1996 StandoutNobel
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Coronavirus disease (COVID-19) cases analysis using machine-learning applications
2021 Standout
A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
2009
Renal-Cell Carcinoma
1996 Standout
Robotics and artificial intelligence in healthcare during COVID-19 pandemic: A systematic review
2021
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
HSP90 and the chaperoning of cancer
2005 Standout
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
2010 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Pancreatic Adenocarcinoma
2014 Standout
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
1993 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
The molecular biology of breast cancer
1991
Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma
1995
Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer
1992
Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer
1990
Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer
1991
The type 1 (EGFR-related) family of growth factor receptors and their ligands
1992
Molecular themes in oncogenesis
1991 StandoutNobel
Gene amplification and tumor progression
1993
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
2014 Standout
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
1994 Standout
Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2
2002
Cell cycle regulatory proteins—an overview with relevance to oral cancer
1997 StandoutNobel
Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients
1992
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Cancer of the Ovary
2004 Standout
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
1992 StandoutScience
A Systematic Review on the Use of AI and ML for Fighting the COVID-19 Pandemic
2020
Amplification of cyclin genes in colorectal carcinomas.
1993
Artificial intelligence, machine learning and deep learning in advanced robotics, a review
2023 Standout
Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
2003 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
1990 StandoutScience
Unlocking the value of artificial intelligence in human resource management through AI capability framework
2022 Standout
Stroke Risk Prediction with Machine Learning Techniques
2022 Standout
Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols
2002 Standout
Works of Dan Assaf being referenced
Amplification of c‐myc and c‐erbB‐2 proto‐oncogenes in human solid tumors: Frequency and clinical significance
1989
Utilization of machine-learning models to accurately predict the risk for critical COVID-19
2020
Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues.
1988